Actively Recruiting
Dongzong Cardiovascular Bio-imaging Registry Study
Led by Jinling Hospital, China · Updated on 2025-03-25
50000
Participants Needed
1
Research Sites
783 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The DAILY project is a large-scale, multicenter, prospective initiative designed to establish a comprehensive bio-imaging database that integrates multidimensional data, including living environments, psychosocial and cognitive assessments, advanced lung and cardiovascular imaging, multi-omics profiles, clinical medication and surgical records, and health outcomes. Leveraging this extensive, multiscale dataset, the project aims to elucidate the intricate interplay between genetic biology and environmental factors in driving downstream biological alterations, thereby shaping lung and cardiovascular structural and functional phenotypes, and ultimately influencing the onset and progression of cardiovascular diseases (CVD). Through a systematic exploration and understanding of this complex network, the project seeks to identify critical intervention points and develop innovative strategies for the prevention and management of CVD.
CONDITIONS
Official Title
Dongzong Cardiovascular Bio-imaging Registry Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 6518 years
- Coronary CT angiography performed
- Informed consent acquired
You will not qualify if you...
- Unable to complete the follow-up
- Serious chronic kidney disease (eGFR < 30 ml/min/1.73 m2)
- Serious liver disease or dysfunction (chronic active hepatitis and cirrhosis, or aspartate aminotransferase (AST) or alanine transaminase (ALT) > 3 times the upper limit of normal)
- Not appropriate to be tested due to birth planning, allergies, acute thyroid storm, etc.
- Suspected or known infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), and Treponema pallidum (syphilis), etc.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Longjiang Zhang
Nanjing, Jiangsu, China, 210002
Actively Recruiting
Research Team
L
Longjiang Zhang, MD
CONTACT
C
Chunxiang Tang, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here